Similarly, expression of PI3K RNAi or TOR RNAi in the RasV12 expressing cells significantly decreases invasive tumour frequency (Fig. 6b, c), showing that RasV12 oncogenic activity depends also on the PI3K/AKT/TOR pathway in the accessory gland. The gene discussed is AKT1; the disease is neoplasm.